-
1
-
-
84983123731
-
Non-alcoholic fatty liver disease (NAFLD) study group, dedicated to the memory of Prof. Paola Loria. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
-
Lonardo A, Bellentani S, Argo CK, , et al., Non-alcoholic fatty liver disease (NAFLD) study group, dedicated to the memory of Prof. Paola Loria. Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups. Dig Liver Dis 2015;47:997-1006.
-
(2015)
Dig Liver Dis.
, vol.47
, pp. 997-1006
-
-
Lonardo, A.1
Bellentani, S.2
Argo, C.K.3
-
2
-
-
77956631214
-
Liver enzymes, nonalcoholic fatty liver disease, incident cardiovascular disease: A narrative review and clinical perspective of prospective data
-
Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010;52:1156-61.
-
(2010)
Hepatology
, vol.52
, pp. 1156-1161
-
-
Ghouri, N.1
Preiss, D.2
Sattar, N.3
-
3
-
-
84951818844
-
Nonalcoholic fatty liver disease and risk of cardiovascular disease
-
Lonardo A, Sookoian S, Pirola CJ, , et al. Nonalcoholic fatty liver disease and risk of cardiovascular disease. Metabolism 2016;65:1135-50.
-
(2016)
Metabolism
, vol.65
, pp. 1135-1150
-
-
Lonardo, A.1
Sookoian, S.2
Pirola, C.J.3
-
4
-
-
84991083809
-
Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
-
Targher G, Byrne CD, Lonardo A, , et al. Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol 2016;65:589-600.
-
(2016)
J Hepatol
, vol.65
, pp. 589-600
-
-
Targher, G.1
Byrne, C.D.2
Lonardo, A.3
-
5
-
-
84986570776
-
Nonalcoholic fatty liver disease and progression of coronary artery calcium score calcification: A retrospective cohort study
-
Sinn DH, Kang D, Chang Y, , et al. Nonalcoholic fatty liver disease and progression of coronary artery calcium score calcification: a retrospective cohort study. Gut 2017;66: 323-9.
-
(2017)
Gut.
, vol.66
, pp. 323-329
-
-
Sinn, D.H.1
Kang, D.2
Chang, Y.3
-
6
-
-
84995489897
-
Persistent nonalcoholic fatty liver disease increases risk for carotid atherosclerosis
-
Sinn DH, Cho SJ, Gu S, , et al. Persistent nonalcoholic fatty liver disease increases risk for carotid atherosclerosis. Gastroenterology 2016;151: 481-8.e1.
-
(2016)
Gastroenterology
, vol.151
, pp. 481-481e1
-
-
Sinn, D.H.1
Cho, S.J.2
Gu, S.3
-
7
-
-
84952673841
-
Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression
-
Bhatia L, Scorletti E, Curzen N, , et al. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression. Atherosclerosis 2016;246: 13-20.
-
(2016)
Atherosclerosis
, vol.246
, pp. 13-20
-
-
Bhatia, L.1
Scorletti, E.2
Curzen, N.3
-
8
-
-
84964575197
-
Fatty liver is an independent predictor of early carotid atherosclerosis
-
Pais R, Giral P, Khan JF, , et al. Fatty liver is an independent predictor of early carotid atherosclerosis. J Hepatol 2016;65:95-102.
-
(2016)
J Hepatol
, vol.65
, pp. 95-102
-
-
Pais, R.1
Giral, P.2
Khan, J.F.3
-
9
-
-
84901480586
-
Ectopic fat, insulin resistance, nonalcoholic fatty liver disease: Implications for cardiovascular disease
-
Byrne CD, Targher G. Ectopic fat, insulin resistance, nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol 2014;34:1155-61.
-
(2014)
Arterioscler Thromb Vasc Biol
, vol.34
, pp. 1155-1161
-
-
Byrne, C.D.1
Targher, G.2
-
10
-
-
84962661546
-
EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease
-
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)
-
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol 2016;64:1388-402.
-
(2016)
J Hepatol
, vol.64
, pp. 1388-1402
-
-
|